Announcements

We are thrilled to announce that this remarkable event saw us raise an astounding £500,000 to further our mission of finding a cure for follicular lymphoma.

The FLF will be attending the prestigious 65th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego this December.

We want to hear from you! Your input and insights will inform our new programme of research around developing biomarkers for follicular lymphoma.

The panel addressed the crucial topic of “Accelerating the Impact of the Cancer Mission Five-Fold” moderated by IQVIA Institutes Executive Director.

Our partnership with LLS continues with the second cycle of the “LLS-FLF United to CURE FL Awards”. This strategic alliance will further accelerate pioneering research and help cure follicular lymphoma.

The FLF joins forces with The Leukemia & Lymphoma Society to bring hope to those living with follicular lymphoma. The partnership marks a significant milestone in accelerating leading edge research.

In just the last six months, we have made tangible progress in advancing research, raising awareness, and working closely with patients.

FLF shines a spotlight on Follicular Lymphoma at upcoming 17-ICML We are thrilled to announce that the Follicular Lymphoma Foundation (FLF) will be taking centre

On May 18th, the FLF hosted our very first webinar called “An Overview of Follicular Lymphoma: What You Need to Know.”

We’re thrilled to share a big step forward in our fight against follicular lymphoma. In April of this year, our founder, Nicola Mendelsohn, officially opened the new branch of the Follicular Lymphoma Foundation in Israel.

The Follicular Lymphoma Foundation (FLF) proudly hosted its first international FL Summit, titled “Joining Forces to Cure Follicular Lymphoma,” in Tel Aviv, Israel. The summit,

FLF are attending the ASH 2022 Annual Meeting We are delighted that some of the team are able to attend the 64th ASH Annual Meeting

New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma. Our mission at the FLF is to

Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director

Dr Mitchell Smith brings to the FLF over three decades of experience focused on blood cancers. The Follicular Lymphoma Foundation (FLF) has today announced the